Veradermics, Inc ( MANE )

Open-market sale

Common stock, par value $0.00001 per share

690,601^{footnote F2}

$107.25

$74.07M

Aug 19, 2026

Open-market sale

Common stock, par value $0.00001 per share

59,399^{footnote F3}

$107.25

$6.37M

Aug 20, 2026

Other

Common stock, par value $0.00001 per share

149,000^{footnote F4}

-^{footnote F6}

Aug 20, 2026

Other

Common stock, par value $0.00001 per share

151,000^{footnote F5}

-^{footnote F6}

Aug 20, 2026

Other

Pre-Funded Warrants

149,000^{footnote F4}

$0.00

Aug 20, 2026

Other

Pre-Funded Warrants

151,000^{footnote F5}

$0.00

Footnote F2 (shares): Notes are included on Exhibit 99.1.
Footnote F3 (shares): Notes are included on Exhibit 99.1.
Footnote F4 (shares): Notes are included on Exhibit 99.1.
Footnote F5 (shares): Notes are included on Exhibit 99.1.
Footnote F6 (price): Notes are included on Exhibit 99.1.

Aug 17, 2026

Timothy August Durso - Officer

Option exercise

Common Stock

3,452

$12.19

$42K

Aug 17, 2026

Timothy August Durso - Officer

Open-market sale

Common Stock

7,918

$106.71^{footnote F1}

$845K

Aug 17, 2026

Timothy August Durso - Officer

Open-market sale

Common Stock

16,306

$107.52^{footnote F2}

$1.75M

Aug 17, 2026

Timothy August Durso - Officer

Open-market sale

Common Stock

16,767

$108.38^{footnote F3}

$1.82M

Aug 17, 2026

Timothy August Durso - Officer

Open-market sale

Common Stock

2,348

$109.34^{footnote F4}

$257K

Aug 17, 2026

Timothy August Durso - Officer

Open-market sale

Common Stock

161

$111.28

$18K

Aug 17, 2026

Timothy August Durso - Officer

Option exercise

Stock Option (Right to Buy)

3,452

$0.00

Footnote F1 (price): The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $106.25 to $106.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange… Full note on SEC EDGAR
Footnote F2 (price): The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $107.00 to $107.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange… Full note on SEC EDGAR
Footnote F3 (price): The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $108.00 to $108.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange… Full note on SEC EDGAR
Footnote F4 (price): The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $109.00 to $109.96, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange… Full note on SEC EDGAR

Aug 17, 2026

Reid Alexander Waldman - Officer

Option exercise

Common Stock

3,452

$12.19

$42K

Aug 17, 2026

Reid Alexander Waldman - Officer

Open-market sale

Common Stock

11,527

$106.72^{footnote F1}

$1.23M

Aug 17, 2026

Reid Alexander Waldman - Officer

Open-market sale

Common Stock

25,234

$107.53^{footnote F2}

$2.71M

Aug 17, 2026

Reid Alexander Waldman - Officer

Open-market sale

Common Stock

27,490

$108.45^{footnote F3}

$2.98M

Aug 17, 2026

Reid Alexander Waldman - Officer

Open-market sale

Common Stock

3,000

$109.38^{footnote F4}

$328K

Aug 17, 2026

Reid Alexander Waldman - Officer

Open-market sale

Common Stock

249

$111.28

$28K

Aug 17, 2026

Reid Alexander Waldman - Officer

Option exercise

Stock Option (Right to Buy)

3,452

$0.00

Footnote F1 (price): The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $106.07 to $107.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange… Full note on SEC EDGAR
Footnote F2 (price): The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $107.00 to $108.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange… Full note on SEC EDGAR
Footnote F3 (price): The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $108.00 to $108.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange… Full note on SEC EDGAR
Footnote F4 (price): The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $109.02 to $109.84, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange… Full note on SEC EDGAR

Aug 12, 2026

John W. Childs - Director

Open-market sale

Common Stock

15,000

$106.14^{footnote F1}

$1.59M

Aug 12, 2026

John W. Childs - Director

Open-market sale

Common Stock

80,000

$107.23^{footnote F3}

$8.58M

Aug 12, 2026

John W. Childs - Director

Open-market sale

Common Stock

5,000

$108.24

$541K

Footnote F1 (price): The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $105.77 to $106.60, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange… Full note on SEC EDGAR
Footnote F3 (price): The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $107.04 to $107.76, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange… Full note on SEC EDGAR

May 1, 2026

Grant or award

Pre-Funded Warrants

149,000^{footnote F2}

$100.00

$14.90M

May 1, 2026

Grant or award

Pre-Funded Warrants

151,000^{footnote F3}

$100.00

$15.10M

Footnote F2 (shares): Notes are included on Exhibit 99.1.
Footnote F3 (shares): Notes are included on Exhibit 99.1.

Feb 5, 2026

John W. Childs - Director

Open-market purchase

Common Stock

294,117

$17.00

$5.00M

Feb 4, 2026

Open-market purchase

Common stock, par value $0.00001 per share

25,908^{footnote F6}

$38.09^{footnote F6}

$987K

Feb 4, 2026

Open-market purchase

Common stock, par value $0.00001 per share

10,004^{footnote F2}

$34.25^{footnote F2}

$343K

Feb 4, 2026

Open-market purchase

Common stock, par value $0.00001 per share

10,676^{footnote F3}

$34.74^{footnote F3}

$371K

Feb 4, 2026

Open-market purchase

Common stock, par value $0.00001 per share

14,659^{footnote F4}

$36.27^{footnote F4}

$532K

Feb 4, 2026

Open-market purchase

Common stock, par value $0.00001 per share

53,344^{footnote F5}

$37.11^{footnote F5}

$1.98M

Feb 4, 2026

Open-market purchase

Common stock, par value $0.00001 per share

18,489^{footnote F7}

$38.90^{footnote F7}

$719K

Feb 4, 2026

Open-market purchase

Common stock, par value $0.00001 per share

1,720^{footnote F8}

$34.25^{footnote F8}

$59K

Feb 4, 2026

Open-market purchase

Common stock, par value $0.00001 per share

1,835^{footnote F9}

$34.74^{footnote F9}

$64K

Feb 4, 2026

Open-market purchase

Common stock, par value $0.00001 per share

2,519^{footnote F10}

$36.27^{footnote F10}

$91K

Feb 4, 2026

Open-market purchase

Common stock, par value $0.00001 per share

9,168^{footnote F11}

$37.11^{footnote F11}

$340K

Feb 4, 2026

Open-market purchase

Common stock, par value $0.00001 per share

4,453^{footnote F12}

$38.09^{footnote F12}

$170K

Feb 4, 2026

Open-market purchase

Common stock, par value $0.00001 per share

3,178^{footnote F13}

$38.90^{footnote F13}

$124K

Feb 5, 2026

Open-market purchase

Common stock, par value $0.00001 per share

3,832^{footnote F14}

$36.07^{footnote F14}

$138K

Feb 5, 2026

Open-market purchase

Common stock, par value $0.00001 per share

19,199^{footnote F15}

$36.93^{footnote F15}

$709K

Feb 5, 2026

Open-market purchase

Common stock, par value $0.00001 per share

38,771^{footnote F16}

$37.63^{footnote F16}

$1.46M

Feb 5, 2026

Open-market purchase

Common stock, par value $0.00001 per share

17,835^{footnote F17}

$38.67^{footnote F17}

$690K

Feb 5, 2026

Open-market purchase

Common stock, par value $0.00001 per share

16,563^{footnote F18}

$39.80^{footnote F18}

$659K

Feb 6, 2026

Open-market purchase

Common stock, par value $0.00001 per share

11,183^{footnote F19}

$35.97^{footnote F19}

$402K

Feb 6, 2026

Open-market purchase

Common stock, par value $0.00001 per share

19,338^{footnote F20}

$36.55^{footnote F20}

$707K

Footnote F2 (price, shares): Notes are included on Exhibit 99.1.
Footnote F3 (price, shares): Notes are included on Exhibit 99.1.
Footnote F4 (price, shares): Notes are included on Exhibit 99.1.
Footnote F5 (price, shares): Notes are included on Exhibit 99.1.
Footnote F6 (price, shares): Notes are included on Exhibit 99.1.
Footnote F7 (price, shares): Notes are included on Exhibit 99.1.
Footnote F8 (price, shares): Notes are included on Exhibit 99.1.
Footnote F9 (price, shares): Notes are included on Exhibit 99.1.
Footnote F10 (price, shares): Notes are included on Exhibit 99.1.
Footnote F11 (price, shares): Notes are included on Exhibit 99.1.
Footnote F12 (price, shares): Notes are included on Exhibit 99.1.
Footnote F13 (price, shares): Notes are included on Exhibit 99.1.
Footnote F14 (price, shares): Notes are included on Exhibit 99.1.
Footnote F15 (price, shares): Notes are included on Exhibit 99.1.
Footnote F16 (price, shares): Notes are included on Exhibit 99.1.
Footnote F17 (price, shares): Notes are included on Exhibit 99.1.
Footnote F18 (price, shares): Notes are included on Exhibit 99.1.
Footnote F19 (price, shares): Notes are included on Exhibit 99.1.
Footnote F20 (price, shares): Notes are included on Exhibit 99.1.

Feb 3, 2026

Katarina Pance

Grant or award

Stock Option (Right to Buy)

43,000

$0.00

Feb 5, 2026

Jane M. Grant-Kels - Director

Other

Common Stock

2,455

-^{footnote F1}

Feb 5, 2026

Jane M. Grant-Kels - Director

Other

Series A Convertible Preferred Stock

2,455

-^{footnote F1}

Feb 3, 2026

Jane M. Grant-Kels - Director

Grant or award

Stock Option (Right to Buy)

51,525

$0.00

Footnote F1 (price): On February 5, 2026, the shares of Series A Convertible Preferred Stock automatically converted into shares of the Issuer's common stock, par value $0.00001 per share, on a 10.067-for-1 basis without payment of further consideration immediately prior to the closing of the… Full note on SEC EDGAR

Feb 3, 2026

David Matthew Friedman - Director

Grant or award

Stock Option (Right to Buy)

43,000^{footnote F1}

$0.00

Footnote F1 (shares): Consists of options to purchase shares of the Issuer's common stock awarded to Mr. Friedman in connection with his role as a member of the Issuer's Board of Directors. Mr. Friedman, as an employee of Suvretta Capital Management, LLC ("Suvretta Capital"), the investment manager… Full note on SEC EDGAR

Feb 5, 2026

Vlad Coric - Director

Other

Common Stock

33,706

-^{footnote F1}

Feb 5, 2026

Vlad Coric - Director

Other

Common Stock

33,706

-^{footnote F1}

Feb 5, 2026

Vlad Coric - Director

Other

Common Stock

148,794

-^{footnote F4}

Feb 5, 2026

Vlad Coric - Director

Other

Common Stock

148,794

-^{footnote F4}

Feb 5, 2026

Vlad Coric - Director

Other

Common Stock

78,075

-^{footnote F5}

Feb 5, 2026

Vlad Coric - Director

Other

Common Stock

78,075

-^{footnote F5}

Feb 5, 2026

Vlad Coric - Director

Other

Common Stock

117,112

-^{footnote F5}

Feb 5, 2026

Vlad Coric - Director

Open-market purchase

Common Stock

58,823

$17.00

$1.00M

Feb 5, 2026

Vlad Coric - Director

Open-market purchase

Common Stock

58,823

$17.00

$1.00M

Feb 5, 2026

Vlad Coric - Director

Other

Series A Convertible Preferred Stock

33,706

-^{footnote F1}

Feb 5, 2026

Vlad Coric - Director

Other

Series A Convertible Preferred Stock

33,706

-^{footnote F1}

Feb 5, 2026

Vlad Coric - Director

Other

Series B Convertible Preferred Stock

148,794

-^{footnote F4}

Feb 5, 2026

Vlad Coric - Director

Other

Series B Convertible Preferred Stock

148,794

-^{footnote F4}

Feb 5, 2026

Vlad Coric - Director

Other

Series C Convertible Preferred Stock

78,075

-^{footnote F5}

Feb 5, 2026

Vlad Coric - Director

Other

Series C Convertible Preferred Stock

78,075

-^{footnote F5}

Feb 5, 2026

Vlad Coric - Director

Other

Series C Convertible Preferred Stock

117,112

-^{footnote F5}

Feb 3, 2026

Vlad Coric - Director

Grant or award

Stock Option (Right to Buy)

51,525

$0.00

Footnote F1 (price): On February 5, 2026, the shares of Series A Convertible Preferred Stock automatically converted into shares of the Issuer's common stock, par value $0.00001 per share ("Common Stock"), on a 10.067-for-1 basis without payment of further consideration immediately prior to the… Full note on SEC EDGAR
Footnote F4 (price): On February 5, 2026, the shares of Series B Convertible Preferred Stock automatically converted into shares of Common Stock on a on a 10.067-for-1 basis without payment of further consideration immediately prior to the closing of the Issuer's initial public offering. The shares… Full note on SEC EDGAR
Footnote F5 (price): On February 5, 2026, the shares of Series C Convertible Preferred Stock automatically converted into shares of Common Stock on a on a 10.067-for-1 basis without payment of further consideration immediately prior to the closing of the Issuer's initial public offering. The shares… Full note on SEC EDGAR

Feb 5, 2026

John W. Childs - Director

Other

Common Stock

480,269

-^{footnote F1}

Feb 5, 2026

John W. Childs - Director

Other

Common Stock

906,862

-^{footnote F3}

Feb 5, 2026

John W. Childs - Director

Other

Common Stock

520,758

-^{footnote F4}

Feb 5, 2026

John W. Childs - Director

Open-market purchase

Common Stock

294,117

$17.00

$5.00M

Feb 5, 2026

John W. Childs - Director

Other

Series A Convertible Preferred Stock

480,269

-^{footnote F1}

Feb 5, 2026

John W. Childs - Director

Other

Series B Convertible Preferred Stock

906,862

-^{footnote F3}

Feb 5, 2026

John W. Childs - Director

Other

Series C Convertible Preferred Stock

520,758

-^{footnote F4}

Feb 3, 2026

John W. Childs - Director

Grant or award

Stock Option (Right to Buy)

51,525

$0.00

Footnote F1 (price): On February 5, 2026, the shares of Series A Convertible Preferred Stock automatically converted into shares of the Issuer's common stock, par value $0.00001 per share ("Common Stock"), on a 10.067-for-1 basis without payment of further consideration immediately prior to the… Full note on SEC EDGAR
Footnote F3 (price): On February 5, 2026, the shares of Series B Convertible Preferred Stock automatically converted into shares of Common Stock on a on a 10.067-for-1 basis without payment of further consideration immediately prior to the closing of the Issuer's initial public offering. The shares… Full note on SEC EDGAR
Footnote F4 (price): On February 5, 2026, the shares of Series C Convertible Preferred Stock automatically converted into shares of Common Stock on a on a 10.067-for-1 basis without payment of further consideration immediately prior to the closing of the Issuer's initial public offering. The shares… Full note on SEC EDGAR

Feb 5, 2026

Other

Common Stock

1,236,631

-^{footnote F1}

Feb 5, 2026

Other

Common Stock

1,171,121

-^{footnote F3}

Feb 5, 2026

Other

Common Stock

1,171,121

-^{footnote F3}

Feb 5, 2026

Open-market purchase

Common Stock

192,647

$17.00

$3.27M

Feb 5, 2026

Open-market purchase

Common Stock

882,353

$17.00

$15.00M

Feb 5, 2026

Other

Series B Convertible Preferred Stock

1,236,631

-^{footnote F1}

Feb 5, 2026

Other

Series C Convertible Preferred Stock

1,171,121

-^{footnote F3}

Feb 5, 2026